GPT Healthcare Limited share price
GPT Healthcare Limited owns and operates a chain of hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology with renal transplants; laparoscopic and general surgery; critical care; pediatrics; gastroenterology; gynecology and obstetrics; interventional cardiology; orthopedics and joint replacement; neurosciences; and others. It also operates clinics and pharmacies, as well as the ILS Agartala Nursing Institute. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.Read more
- Market Cap₹ 1,155 Cr.
- Current Price₹ 140.74
- High / Low₹ 175 / 115
- Stock P/E24.4
- Book Value₹ 33
- Dividend Yield2.15 %
- ROCE16.2 %
- ROE16.30 %
- Face Value₹ 10.0
More figures (10)
- EPS (TTM)₹ 5.76
- Price / Book4.29
- OPM12.4 %
- Debt / Equity0.34
- Sales growth (3Y)9.6 %
- Profit growth (3Y)2.7 %
- Promoter holding66.8 %
- EV / EBITDA14.6
- Beta0.31
- All-time high₹ 220
Price chart
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| GPTHEALTH | -13.82% | -8.48% | +3.57% | +0.28% | -4.15% | — | — |
| Nifty 50 | -0.31% | -3.85% | -4.34% | -11.42% | -9.53% | +5.46% | +4.76% |
Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.
Quick take
- GPT Healthcare Limited is in the Medical Care Facilities industry (Healthcare), with a market value of ₹1,155 crore.
- It trades at 24.4 times its last 12 months' earnings and 4.3 times book value.
- Revenue grew 9.6% a year over the last 3 years, profit 2.7% a year.
- Return on equity was 16.3% and return on capital employed 16.2% in the latest year.
- Debt was 0.34 times shareholders' equity.
- The share price is 19.6% below its 52-week high and down 4.2% over one year.
- Promoters and insiders hold about 66.8%; institutions about 7.4%.
Pros
AI- Strong return on equity: 20.9% on average over the last 3 years.
- Latest quarter (Jun 2026): sales up 18% and profit up 66% from a year ago.
- Borrowings are moderate at 0.34 times shareholders' equity.
- Pays a healthy dividend: about 49% of profit last year.
- Promoters hold a large stake of 65.57%.
Cons
AI- Institutional (FII + DII) holding has fallen by 9.5 points over 10 quarters.
Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.
AI analysis
Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.
About GPT Healthcare Limited
GPT Healthcare Limited owns and operates a chain of hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology with renal transplants; laparoscopic and general surgery; critical care; pediatrics; gastroenterology; gynecology and obstetrics; interventional cardiology; orthopedics and joint replacement; neurosciences; and others. It also operates clinics and pharmacies, as well as the ILS Agartala Nursing Institute. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.
- Employees
- 2,124
- Head office
- Kolkata
Peer comparison
HealthcareMedical Care Facilities
| S.No. | Company | CMP ₹ | P/E | Mar Cap ₹ Cr | Div Yld % | NP Qtr ₹ Cr | Qtr Profit Var % | Sales Qtr ₹ Cr | Qtr Sales Var % | ROCE % | ROE % | P/B | OPM % | Debt / Eq | Prom. Hold. % | Sales ₹ Cr | Sales Var 3Yrs % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | GPT Healthcare | 140.74 | 24.4 | 1,155 | 2.15 | 13 | 65.73 | 126 | 17.83 | 16.2 | 16.3 | 4.29 | 12.4 | 0.34 | 66.77 | 473 | 9.6 |
| 2. | Apollo Hospitals Enterprise | 7,890.00 | 54.3 | 1,13,446 | 0.25 | 581 | 49.05 | 7,044 | 25.95 | 19.2 | 21.9 | 11.97 | 11.7 | 0.90 | 28.39 | 24,911 | 14.8 |
| 3. | Max Healthcare Institute | 846.00 | 56.7 | 82,342 | 0.23 | 323 | 4.87 | 2,366 | 16.70 | 12.6 | 14.3 | 7.66 | 22.8 | 0.32 | 28.20 | 8,225 | 22.4 |
| 4. | Aster DM Quality Care | 674.35 | 109.3 | 58,781 | 0.44 | 29 | -68.70 | 1,311 | 21.60 | 9.4 | 9.7 | 7.59 | 14.2 | 0.49 | 64.26 | 4,643 | 15.7 |
| 5. | Fortis Healthcare | 736.50 | 53.1 | 55,603 | 0.13 | 266 | 2.35 | 2,545 | 17.46 | 11.9 | 11.1 | 5.62 | 17.8 | 0.35 | 35.19 | 9,048 | 13.3 |
| 6. | Narayana Hrudayalaya | 1,719.40 | 42.5 | 34,921 | 0.26 | 207 | 5.35 | 2,684 | 78.05 | 11.4 | 19.7 | 7.70 | 15.5 | 1.29 | 67.23 | 7,858 | 20.5 |
| 7. | Global Health | 1,240.00 | 60.0 | 33,322 | 0.04 | 159 | -0.18 | 1,304 | 26.50 | 15.0 | 15.1 | 8.41 | 16.8 | 0.30 | 66.39 | 4,318 | 17.2 |
| 8. | Krishna Institute of Medical Sciences | 685.60 | 134.4 | 28,796 | 0.00 | 42 | -47.20 | 1,180 | 35.33 | 8.1 | 11.0 | 12.21 | 13.8 | 1.89 | 41.74 | 3,872 | 21.3 |
| 9. | Rainbow Children's Medicare | 1,248.90 | 44.4 | 12,634 | 0.28 | 63 | 16.23 | 470 | 33.17 | 16.8 | 17.9 | 7.69 | 23.7 | 0.54 | 52.29 | 1,703 | 13.1 |
| 10. | Park Medi World | 235.70 | 35.9 | 10,181 | 0.00 | 83 | 42.30 | 476 | 19.27 | 17.9 | 16.8 | 4.64 | 23.3 | 0.18 | 83.94 | 1,651 | 9.6 |
| Median: 14 Co. | 791.25 | 53.7 | 20,715 | 0.18 | 121 | 5.11 | 1,307 | 23.78 | 13.8 | 15.7 | 7.68 | 16.2 | 0.42 | 58.28 | 4,481 | 16.5 |
Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.
Quarterly Results
Standalone figures in ₹ crore
Source: the company's results filed with NSE, as reported. EPS restated for bonus issues and splits. Tap a row marked + for its breakdown. Latest quarter on the right.
Profit & Loss
Standalone figures in ₹ crore
Projection — your assumptions
Starts from the last four reported quarters (TTM) and applies the figures you enter; growth is pre-filled with the company's own past sales growth. This is a what-if calculator for illustration, not a forecast, estimate or recommendation.
Related party transactions
Related-party transactions are dealings with promoters, directors, subsidiaries and associates. Companies disclose them to the exchanges every half-year and in detail in the notes to their annual report.
No separate related-party filing among the recent announcements of the company.
Full details: notes to the Financial Year 2026 annual report (related party disclosures).
| ₹ Cr | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|
| 400 | 407 | 473 | 492 | |
| YOY Sales Growth % | 1.72% | 16.08% | ||
| 312 | 324 | 388 | 401 | |
| Material Cost % | 21% | 19% | 19% | 19% |
| Employee Cost % | 17% | 18% | 18% | 18% |
| Other Expenses % | 40% | 42% | 45% | 45% |
| Operating Profit | 88 | 83 | 84 | 91 |
| OPM % | 22% | 20% | 18% | 19% |
| Other Income | 5 | 8 | 6 | 6 |
| Interest | 7 | 3 | 8 | 9 |
| Depreciation | 18 | 19 | 27 | 28 |
| Profit before tax | 68 | 69 | 55 | 61 |
| 30% | 28% | 23% | 22% | |
| Current tax | 12 | 12 | 13 | |
| Deferred tax | 8 | 7 | 0 | |
| 48 | 50 | 42 | 47 | |
| YOY Profit Growth % | 4.51% | -15.43% | ||
| EPS in Rs | 5.96 | 6.08 | 5.15 | 5.76 |
| Dividend Payout % | 50% | 58% | 49% |
Compounded Sales Growth
- TTM:
- 18%
Compounded Profit Growth
- TTM:
- -1%
Stock Price CAGR
- 1 Year:
- -4%
Return on Equity
- 4 Years:
- 22%
- Last Year:
- 16%
Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. EPS restated for bonus issues and splits. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.
Balance Sheet
Consolidated figures in ₹ crore, as at 31 March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 80 | 82 | 82 | 82 |
| Reserves | 85 | 136 | 166 | 187 |
| 82 | 31 | 35 | 91 | |
| Long term borrowings | 40 | 4 | 6 | 7 |
| Short term borrowings | 24 | 9 | 8 | 9 |
| 79 | 96 | 101 | 104 | |
| Trade payables | 33 | 37 | 35 | 42 |
| Current liabilities | 82 | 77 | 74 | 79 |
| Total Liabilities | 327 | 346 | 384 | 465 |
| 231 | 230 | 277 | 344 | |
| Gross block | 298 | 310 | 374 | 467 |
| Accumulated depreciation | 67 | 80 | 97 | 123 |
| Goodwill & intangibles | 0 | 1 | 1 | 0 |
| CWIP | 3 | 7 | 50 | 2 |
| 93 | 108 | 57 | 118 | |
| Inventories | 9 | 8 | 9 | 11 |
| Trade receivables | 21 | 24 | 20 | 20 |
| Cash & equivalents | 7 | 2 | 2 | 4 |
| Current assets | 81 | 80 | 79 | 89 |
| Total Assets | 327 | 346 | 384 | 465 |
Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.
Cash Flows
Consolidated figures in ₹ crore, financial years ending March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 66 | 69 | 67 | 81 | |
| Profit for the year | 39 | 48 | 50 | 42 |
| Working capital changes | 2 | -6 | -4 | 6 |
| Direct taxes paid | -10 | -15 | -17 | -13 |
| 5 | -25 | -33 | -47 | |
| Fixed assets purchased | -10 | -19 | -50 | -42 |
| Fixed assets sold | 1 | 0 | 0 | 1 |
| Investments purchased | -10 | -36 | -19 | -37 |
| Investments sold | 5 | 14 | 20 | 28 |
| -73 | -49 | -35 | -31 | |
| Proceeds from borrowings | 0 | 9 | 14 | |
| Repayment of borrowings | -30 | -53 | -9 | -9 |
| Interest paid | -8 | -5 | -2 | -2 |
| Dividends paid | -32 | -24 | -29 | -21 |
| Net Cash Flow | -2 | -5 | -0 | 2 |
| Free Cash Flow | 56 | 49 | 17 | 39 |
Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.
Ratios
| Ratio | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| ROE | 23.6% | 24.9% | 21.4% | 16.3% |
| ROCE | 26.3% | 27.8% | 23.2% | 16.2% |
| Operating margin | 16.8% | 18.2% | 16.9% | 12.4% |
| Net margin | 10.9% | 12.0% | 12.3% | 8.9% |
| Debt / equity | 0.50 | 0.14 | 0.14 | 0.34 |
| Current ratio | 0.99 | 1.04 | 1.06 | 1.12 |
| Debtor days | 21 | 22 | 18 | 16 |
| Inventory days | 24 | 20 | 22 | 23 |
| Days payable | 91 | 93 | 86 | 91 |
| Cash conversion cycle | -46 | -51 | -46 | -52 |
| Working capital days | -1 | 3 | 4 | 8 |
Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.
Shareholding Pattern
Numbers in percentages · as filed with NSE each quarter
- Promoters 65.57%
- FIIs 3.03%
- DIIs 6.94%
- Public 24.46%
| % | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% |
| 6.68% | 5.38% | 4.70% | 4.72% | 4.48% | 4.96% | 3.20% | 2.74% | 2.81% | 3.03% | |
| Foreign portfolio investors (Cat. I) | 3.49% | 2.04% | 1.34% | 1.35% | 1.21% | 1.50% | 0.29% | 0.05% | 0.13% | 0.19% |
| Foreign portfolio investors (Cat. II) | 3.19% | 3.34% | 3.36% | 3.36% | 3.28% | 3.46% | 2.91% | 2.68% | 2.68% | 2.84% |
| 12.81% | 13.08% | 11.99% | 11.30% | 11.35% | 9.32% | 6.46% | 6.20% | 6.83% | 6.94% | |
| Mutual funds | 8.43% | 8.52% | 7.43% | 6.64% | 6.65% | 4.31% | 4.64% | 4.72% | 4.69% | 4.65% |
| Insurance companies | 3.18% | 3.34% | 3.37% | 3.46% | 3.50% | 3.50% | 0.02% | 0.01% | 0.01% | |
| Alternative investment funds | 0.02% | 0.32% | 0.57% | 0.75% | 0.94% | 1.09% | ||||
| 14.94% | 15.96% | 17.73% | 18.41% | 18.59% | 20.15% | 24.76% | 25.49% | 24.78% | 24.46% | |
| Retail (up to ₹2 lakh) | 10.54% | 11.92% | 13.81% | 13.63% | 13.62% | 14.13% | 15.68% | 15.92% | 15.38% | 15.01% |
| HNIs (above ₹2 lakh) | 1.62% | 1.68% | 1.26% | 1.70% | 1.94% | 2.52% | 3.22% | 3.19% | 2.95% | 3.00% |
| NRIs | 0.11% | 0.17% | 0.50% | 0.53% | 0.59% | 0.58% | 0.55% | 0.57% | 0.63% | 0.63% |
| Bodies corporate | 2.06% | 1.41% | 1.46% | 1.68% | 1.62% | 1.79% | 3.77% | 4.39% | 4.14% | 4.19% |
| No. of Shareholders | 76,664 | 71,293 | 74,737 | 70,147 | 68,365 | 67,060 | 67,617 | 66,626 | 64,075 | 62,454 |
Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.
Mutual funds & institutions holding GPT Healthcare
| Holder (above 1%) | Stake |
|---|---|
| BANDHAN Small Cap FundMutual fund | 4.65% |
As named in the shareholding pattern for Jun 2026 filed with NSE; mutual funds together hold 4.65% of the company. Shareholders below 1% are not named in the filing.
Documents
Announcements
- Certificate under SEBI (Depositories and Participants) Regulations, 2018GPT Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 201808-Oct-2026
- Trading WindowGPT Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201528-Sep-2026
- Shareholders meetingGPT Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 06, 2026. Further, the company has informed the Exchange regar…07-Aug-2026
- Shareholders meetingGPT Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 06, 202606-Aug-2026
- Copy of Newspaper PublicationGPT Healthcare Limited has informed the Exchange about Copy of Newspaper Publication04-Aug-2026
- Press ReleasePress Release on UFR for Q1FY202703-Aug-2026
- Outcome of Board MeetingGPT Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.03-Aug-2026
- Certificate under SEBI (Depositories and Participants) Regulations, 2018GPT Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 201811-Jul-2026
- Copy of Newspaper PublicationGPT Healthcare Limited has informed the Exchange about Copy of Newspaper Publication10-Jul-2026
- General UpdatesGPT Healthcare Limited has informed the Exchange about General Updates09-Jul-2026
- Shareholders meetingGPT Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 06, 202609-Jul-2026
- Copy of Newspaper PublicationGPT Healthcare Limited has informed the Exchange about Copy of Newspaper Publication03-Jul-2026
Annual reports
Credit ratings
None filed recently.
Concalls & investor meets
- Analysts/Institutional Investor Meet/Con. Call UpdatesGPT Healthcare Limited has informed the Exchange about Schedule of meet21-Sep-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesGPT Healthcare Limited has informed the Exchange about Transcript07-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesGPT Healthcare Limited has informed the Exchange about Link of Recording04-Aug-2026
- Investor PresentationGPT Healthcare Limited has informed the Exchange about Investor Presentation03-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesGPT Healthcare Limited has informed the Exchange about Schedule of meet25-Jul-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesGPT Healthcare Limited has informed the Exchange about Schedule of meet05-Jun-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesGPT Healthcare Limited has informed the Exchange about Transcript22-May-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesGPT Healthcare Limited has informed the Exchange about Link of Recording19-May-2026
- Investor PresentationGPT Healthcare Limited has informed the Exchange about Investor Presentation18-May-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesGPT Healthcare Limited has informed the Exchange about Schedule of meet11-May-2026
Filings made by the company with NSE; documents open on NSE's website.
Key dates
- Ex-dividend date
- 30 Jul 2026
- Latest quarter
- 30 Jun 2026
- Financial year end
- 31 Mar 2026
Trade with our broking desk
Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.
Latest news
From the company (NSE)
- Certificate under SEBI (Depositories and Participants) Regulations, 2018GPT Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018NSE filing · 08-Oct-2026
- Trading WindowGPT Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015NSE filing · 28-Sep-2026
- Shareholders meetingGPT Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 06, 2026. Further, the company has informed the Exchange regar…NSE filing · 07-Aug-2026
- Shareholders meetingGPT Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 06, 2026NSE filing · 06-Aug-2026
- Copy of Newspaper PublicationGPT Healthcare Limited has informed the Exchange about Copy of Newspaper PublicationNSE filing · 04-Aug-2026
- Press ReleasePress Release on UFR for Q1FY2027NSE filing · 03-Aug-2026
- Outcome of Board MeetingGPT Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.NSE filing · 03-Aug-2026
- Certificate under SEBI (Depositories and Participants) Regulations, 2018GPT Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018NSE filing · 11-Jul-2026
Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.
Questions about GPT Healthcare Limited
What is the share price of GPT Healthcare Limited today?
What is the market cap of GPT Healthcare Limited?
What is the P/E ratio of GPT Healthcare Limited?
Is GPT Healthcare Limited a good investment?
How can I buy GPT Healthcare Limited shares?
Have a question about this topic?
Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.
Book your free wealth consultation
- 100% free
- No obligation
- Reply within 2 hours
Request received!
Thank you for trusting Plenitude Connect. An expert will contact you shortly. Please check your inbox for details.